Purpose: To describe the non-exenteration management of sino-orbital fungal infection, a life-threatening condition for which orbital exenteration is generally considered a first-line treatment.
Methods: A retrospective case series is presented of 7 orbits in 6 consecutive patients admitted and treated at 2 major metropolitan tertiary teaching hospitals in Sydney, New South Wales, Australia.
Results: Seven orbits in 6 consecutive patients with sino-orbital fungal infection were treated conservatively with surgical debridement and intravenous antifungal agents. Four patients were immunosuppressed and the other 2 patients were otherwise healthy. All presented with pain, proptosis, or loss of vision. Causative organisms found were Mucormycoses, Aspergillus, and Scedosporium prolificans. Exenteration was avoided in all patients as part of their planned management and 5 patients, including 1 with bilateral disease, survived their disease without exenteration. Medical treatment included intravenous liposomal amphotericin B or voriconazole. A single immunosuppressed patient deteriorated and as a last resort, exenteration was performed, but this made no difference to his clinical course and in retrospect could have been avoided as he died of multiple cerebral metastases diagnosed shortly after his deterioration.
Conclusion: The authors recommend that patients with sino-orbital fungal disease preferably be treated conservatively, without orbital exenteration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/IOP.0000000000000812 | DOI Listing |
Am J Trop Med Hyg
January 2025
King's College Hospital NHS Foundation Trust, London, United Kingdom.
We report a case of co-infection with Aspergillus fumigatus causing invasive sino-orbital aspergillosis and Trichophyton interdigitale tinea corporis in a returned traveler from flooded Sylhet region, Bangladesh. Anthropogenic climate change may lead to increased extreme weather-associated fungal infections. Travel to a flooded area should be considered a risk factor for fungal infection.
View Article and Find Full Text PDFIndian J Ophthalmol
October 2024
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Med J Armed Forces India
October 2022
Professor (Ocular Pharmacology), Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, Delhi, India.
Background: The aim of the study was to evaluate the outcomes of voriconazole in terms of functional recovery and response on imaging in the management of invasive aspergillosis of orbit.
Methods: This was a prospective non-comparative interventional study Diagnosed cases of invasive orbital aspergillosis were studied in a tertiary care hospital. Intravenous voriconazole followed by oral treatment was given.
J Am Anim Hosp Assoc
September 2024
Department of Dermatology, Kanazawa Medical University, Ishikawa, Japan (K.A.).
Int Ophthalmol
July 2024
The University of Adelaide, Adelaide, SA, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!